AbbVie Draws Growing Institutional Confidence As Investors Seek Steady Growth

Image source: Getty ImagesLOS ANGELES CAPITAL MANAGEMENT LLC increased its position in AbbVie by 304,281 shares during Q3 2025, an estimated $61.96 million trade based on the average price for Q3 2025, according to its October 20, 2025, SEC filing.LOS ANGELES CAPITAL MANAGEMENT LLC disclosed in its October 20, 2025, filing with the U.S. Securities and Exchange Commission (SEC filing) that it purchased an additional 304,281 shares of AbbVie (NYSE:ABBV) in Q3 2025. The estimated value of the transaction was $61.96 million. The fund held a total of 2,324,286 AbbVie shares.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool